Satsuma Pharmaceuticals, Inc.
STSADelisted Jun 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001692830
Satsuma Pharmaceuticals, Inc. was delisted on Jun 8, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 31 institutions reported holding it in 13F filings for Q1 2023, worth $12.7M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Satsuma Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 45 | 2 | 35 | −8 |
| Shares | 23.2M | 1.90M | 23.0M | +1.71M (+8.0%) |
| Value | $108.3M | $8.87M | $103.6M | +$4.25M (+4.3%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Satsuma Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TPG GP A, LLC | 1,885,939 | $8.49M | 0.08% |
| Bank of America Corp | 4,297 | $19.0K | 0.00% |
| Simplex Trading, LLC | 177 | $0 | 0.00% |
| UBS Group AG | 25 | $0 | 0.00% |
Sold out (12)
Institutions that held Satsuma Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Maven Securities LTD | 157,612 | $730.0K |
| Gsa Capital Partners LLP | 90,665 | $422.0K |
| Jacobs Levy Equity Management, Inc | 78,535 | $366.0K |
| Millennium Management LLC | 60,108 | $280.0K |
| Renaissance Technologies LLC | 41,664 | $194.0K |
| PDT Partners, LLC | 15,000 | $70.0K |
| Chicago Partners Investment Group LLC | 11,150 | $68.0K |
| D. E. Shaw & Co., Inc. | 11,232 | $52.0K |
| Occudo Quantitative Strategies LP | 10,845 | $51.0K |
| Acadian Asset Management LLC | 5,253 | $24.0K |
| ClariVest Asset Management LLC | 612 | $3.00K |
| Federated Hermes, Inc. | 441 | $2.00K |
Not filed for Q4 2021 yet (2)
Institutions that held Satsuma Pharmaceuticals, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8.79M |
| Marshall Wace North America L.P. | 16,888 | $79.0K |